To delineate the role of ATR in SLE pathogenesis, we first sought to profile cytokine production following ATR inhibition in IFN-α–treated B cells, considering that B cells represent a rich source of various cytokines, which are broadly perturbed in SLE. Here, ATR is linked to systemic lupus erythematosus.